TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.830
-0.100 (-2.03%)
Aug 28, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $297.41 million as of August 28, 2026. Its market cap has increased by 16.94% in one year.
Market Cap
297.41M
Enterprise Value
285.54M
1-Year Change
16.94%
Ranking
Category
Stock Price
$4.83
ChartMarket Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $297.41M, a decrease of -9.53%. That is a compound annual growth rate of -1.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 297.41M | -14.72% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mobia Medical | 377.52M |
| Perspective Therapeutics | 355.01M |
| Viemed Healthcare | 335.94M |
| AVITA Medical | 320.09M |
| Treace Medical Concepts | 302.41M |
| CapsoVision | 296.78M |
| RxSight | 293.23M |
| Standard BioTools | 252.00M |